Limerick Biopharma Trademark Details
Word Mark | Limerick Biopharma |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Limerick Biopharma, Inc. of South San Francisco, CA
View all trademarks for Limerick Biopharma, Inc.Serial Number | 85010595 |
---|---|
Status Date | Monday, July 30, 2012 |
Filing Date | Monday, July 30, 2012 |
Attorney | Julie L. Dalke |
Correspondent
Julie L. Dalke
Latham & Watkins LLP
650 Town Center Dr, 20th fl
Costa Mesa CA 92626
Latham & Watkins LLP
650 Town Center Dr, 20th fl
Costa Mesa CA 92626
Case File Statements
Disclaimer with Predetermined Text | "Biopharma" |
---|---|
Goods & Services | pharmaceutical preparations for the treatment of Tangiers disease, nonalcoholic steatohepatitis (NASH), non-alcoholic fatty liver disease (NAFLD), cystic fibrosis, human immunodeficiency virus (HIV), diabetes, hyperlipidemia, cancer, atherosclerosis, hypertension, insulin resistance, dyslipidemia, and hepatic cholestasis; pharmaceutical preparations for the treatment of the metabolic system, the central nervous system, the peripheral nervous system, the liver, the immune system, the renal system, and the cardiovascular system; pharmaceutical preparations for the treatment of metabolic diseases and disorders, infectious diseases, autoimmune diseases and disorders, inflammatory disorders, and cardiovascular disease; pharmaceutical preparations for the treatment of renal diseases, disorders and dysfunction; pharmaceutical preparations for the prevention and treatment of organ rejection; pharmaceutical preparations for use in tissue and organ transplantation, for adjuvant use in tissue and organ transplantation, for use in oncology, and for use in chemotherapy; pharmaceutical preparations and substances for the treatment of viral related diseases and disorders, and immune system related diseases and disorders; pharmaceutical preparations and substances for the treatment of pain; pharmaceuticals, namely, anti-infectives, immunosuppressants, anti-inflamatories, and antivirals; analgesic pharmaceutical preparations; anti-diabetic pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals |
Pseudo Mark | Limerick Biological Pharmaceutical |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Wednesday, April 14, 2010 |
Primary Code | 005 |
Trademark Timeline
-
Apr 09 2010Trademark application filed with USPTO
-
Apr 13 2010New Application Entered In Tram
-
Apr 14 2010New Application Office Supplied Data Entered In Tram
-
Apr 15 2010Notice of Pseudo Mark Mailed
-
Jul 14 2010Assigned To Examiner
-
Jul 21 2010Notification of Non-Final Action E-Mailed
-
Jul 21 2010Non-Final Action E-Mailed
-
Jul 21 2010Non-Final Action Written
-
Sep 15 2010Teas/email Correspondence Entered
-
Sep 15 2010Correspondence Received In Law Office
-
Sep 15 2010Teas Response To Office Action Received
-
Sep 17 2010Approved For Pub - Principal Register
-
Sep 27 2010Law Office Publication Review Completed
-
Sep 27 2010Assigned To Lie
-
Nov 02 2010Official Gazette Publication Confirmation E-Mailed
-
Nov 02 2010Published For Opposition
-
Dec 28 2010Noa E-Mailed - Sou Required From Applicant
-
Jun 10 2011Extension 1 Granted
-
Jun 10 2011Extension 1 Filed
-
Jun 10 2011Teas Extension Received
-
Jun 14 2011Notice of Approval of Extension Request E-Mailed
-
Dec 15 2011Extension 2 Filed
-
Dec 15 2011Teas Extension Received
-
Jan 18 2012Extension 2 Granted
-
Jan 18 2012Case Assigned To Intent To Use Paralegal
-
Jan 19 2012Notice of Approval of Extension Request E-Mailed
-
Jul 30 2012Abandonment Notice Mailed - No Use Statement Filed
-
Jul 30 2012Abandonment - No Use Statement Filed